ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Símbolo de cotizaciónASPI
Nombre de la empresaASP Isotopes Inc
Fecha de salida a bolsaNov 10, 2022
Director ejecutivoMr. Paul Elliot Mann
Número de empleados136
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 10
Dirección601 Pennsylvania Avenue Nw
CiudadWASHINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal20004
Teléfono12027562245
Sitio Webhttps://aspisotopes.com/
Símbolo de cotizaciónASPI
Fecha de salida a bolsaNov 10, 2022
Director ejecutivoMr. Paul Elliot Mann
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos